News

Following two phase 2a studies that were conducted by Topigen with TPI 1020 in patients with asthma and COPD, NicOx and Topigen had recently been in active discussions

The agreement includes distribution in the US, Canada and Puerto Rico, and expands Sigma-Aldrich’s portfolio of chromatography solutions offered through its Supelco brand. In addition to the classic

According to the company, Zadaxin treatment given with the H1N1 vaccine led to a significant (p value < 0.01) increase in the percentage of subjects who seroconverted at

Reportedly, the ability to produce VaxInnate’s recombinant vaccine in a bacterial expression system will enable BE to manufacture vaccine at the company’s existing biotechnology facilities with microbial production

The new line produces high-performance polyester films, which will support the fast growing UK market. Klockner Pentaplast invested £3 Mio (E3.4 Mio /$4.4 Mio) for the expansion, with

ACH-1625 is an inhibitor of HCV NS3 protease that was discovered and is being developed by Achillion. HCV-infected subjects in the second dosing cohort (n=9, randomized to 6

XRX-001 is an inactivated virus vaccine adsorbed to alum adjuvant. As it is inactivated and non-replicating, it is anticipated to reduce the risks of serious and fatal adverse

Symbicort Turbuhaler is a twice-daily treatment for adult bronchial asthma combining budesonide, an inhaled corticosteroid (one dose containing 160µg) and formoterol fumarate dihydrate, a rapid and long acting

Reportedly, based on the investigation, McNeil Consumer Healthcare has determined that the reported uncharacteristic smell is caused by the presence of trace amounts of a chemical called 2,4,6-tribromoanisole